Alan Watt is a highly experienced professional currently serving as Chief Executive Officer at NodThera, a biotech company specializing in innate immune/ inflammasome research. Alan also holds various other positions such as Visiting Lecturer at ESCP Business School and Non Executive Director at Babraham Institute Enterprise Ltd. With a background in Chemistry, an MBA, and a PhD in Drug Metabolism, Alan has played key roles in the biotech industry, including as Co-founder and Science Director at XenoVida. Alan's expertise spans across drug discovery, development, and leadership training in various organizations like Trident Pharmaceuticals and Bicycle Therapeutics.
NodThera
NodThera is a biotechnology company focused on the discovery and development of new treatments for diseases.